Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

BACKGROUND: The lower sales price of generic lamivudine has caused healthcare administrators to consider abolishing fixed-dose antiretroviral combinations (FDCs) that contain lamivudine and emtricitabine. The alternative is to administer the individual components of the FDCs separately, thus incorpo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Homar, Francesc, Lozano, Virginia, Martínez-Gómez, Juan, Oyagüez, Itziar, Pareja, Antonio, Payeras, Antoni, Serrano, Joaquín, Carratalá, Carmen, Casado, Miguel Ángel
Format: Artigo
Idioma:Inglês
Publicat: Springer 2012
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3484113/
https://ncbi.nlm.nih.gov/pubmed/22943676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-2-16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars